Functional determinants of the Epstein-Barr virus protease

Journal of Molecular Biology

Volumn 311, Issue 1, 2001, Pages 217-228

  Buisson, Marlyse ^a,b,c   Valette, Erika ^c,d   Hernandez, Jean François ^d   Baudin, Florence ^b,c   Ebel, Christine ^d   Morand, Patrice ^a,b   Seigneurin, Jean Marie ^a,b   Arlaud, Gérard J ^d   Ruigrok, Rob W H ^b,c  

^a HÔPITAL MICHALLON   (France)

^b UNIV GRENOBLE ALPES   (France)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^d INSTITUT DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Cancer; Herpesvirus; Infectious mononucleosis; Protease; Virus assembly

Indexed keywords

GLYCEROL; MONOMER; PROTEINASE; VIRUS DNA; VIRUS ENZYME;

ARTICLE; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN ASSEMBLY; PROTEIN PURIFICATION; SEQUENCE ANALYSIS;

EID: 0035800672     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.4854     Document Type: Article

References (55)

1. Epstein-Barr virus
2. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication
3. Acyclovir for treatment of infectious mononucleosis: A meta-analysis
4. Virostatic therapy for advanced lymphoproliferation associated with the Epstein-Barr virus in an HIV-infected patient
5. Characterization of the Epstein-Barr virus proteinase and comparison with the human cytomegalovirus proteinase
6. The herpesvirus proteases as targets for antiviral chemotherapy
7. The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth
8. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease
9. Identification of the serine residue at the active site of the herpes simplex virus type 1 protease
10. Unique fold and active site in cytomegalovirus protease
11. Three-dimensional structure of human cytomegalovirus protease
12. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease
13. Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad
14. Crystal structure of varicella-zoster virus protease
15. Active site cavity of herpesvirus proteases revealed by the crystal structure of herpes simplex virus protease/inhibitor complex
16. Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: Regulation of activity and dimerization by conserved structural elements
17. Peptide substrate cleavage specificity of the human cytomegalovirus protease
18. In vitro activity of the herpes simplex virus type 1 protease with peptide substrates
19. Conserved mode of peptidomimetic inhibition and substrate recognition of human cytomegalovirus protease
20. Identification of a novel peptide substrate of HSV-1 protease using substrate phage display
21. Dimerization of the human cytomegalovirus protease: Kinetic and biochemical characterization of the catalytic homodimer
22. Active human cytomegalovirus protease is a dimer
23. Dimerization and activation of the herpes simplex virus type 1 protease
24. Human cytomegalovirus maturational proteinase: Expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites
25. Single-chain recombinant human cytomegalovirus protease. Activity against its natural protein substrate and fluorogenic peptide substrates
26. Activation of the herpes simplex virus type 1 protease
27. Stimulation of the herpes simplex virus type I protease by antichaeotrophic salts
28. Auto-inactivation by cleavage within the dimer interface by Kaposi's Sarcoma-associated Herpesvirus protease
29. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling
30. Characterization of human cytomegalovirus protease dimerization by analytical centrifugation
31. On the size of the active site in proteases. I. Papain
32. Activity in monomers of human cytomegalovirus protease
33. Autoprocessing and peptide substrates for human herpesvirus 6 proteinase
34. Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics
35. Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation
36. Peptidomimetic inhibitors of the human cytomegalovirus protease
37. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies
38. The 2.9 Å crystal structure of T. thermophilus seryl-tRNA synthetase complexed with tRNA(Ser)
39. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease
40. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
41. + plasma etching to localise structural proteins in the capsid of herpes simplex virus type 1
42. Structure of the herpes virus capsid: Effects of extraction with guanidine hydrochloride and partial reconstitution of extracted capsids
43. The herpes simplex virus procapsid: Structure, conformational changes upon maturation, and roles of the triplex proteins VP19c and VP23 in assembly
44. Identification of the sites of interaction between the scaffold and outer shell in herpes simplex virus-1 capsids by difference electron imaging
45. Isolation of herpes simplex virus procapsids from cells infected with a protease-deficient mutant virus
46. Self-association of herpes simplex virus type 1 ICP35 is via coiled-coil interactions and promotes stable interaction with the major capsid protein
47. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity
48. Structure and assembly of the catalytic region of human complement protease C1r: A three-dimensional model based on chemical cross-linking and homology modeling
49. Evaluation of secondary structure of proteins from UV circular, dichroism spectra using an unsupervised learning neural network
50. Quantitative analysis of protein far UV circular dichroism spectra by neural networks
51. Boundary analysis in sedimentation velocity experiments
52. Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid
53. Direct sedimentation analysis of interference optical data in analytical ultracentrifugation
54. Solid phase peptide synthesis
55. Analysis of the N-linked oligosaccharides of human C1 s using electrospray ionisation mass spectrometry